Stocks To Buy Now

Blog


New Jersey to Host 21st BioPharma Clinical Trials Nexus

Solution providers and innovators of the pharma and healthcare industry, as well as experts in clinical trials, are invited to attend the 21st Biopharma Clinical Trials Nexus at the Holiday Inn Piscataway, Somerset, in New Jersey. This is an invite-only event that will be held from October 22, 2024, to October 23, 2024.

BioPharma Nexus focuses on creating synergies between leading pharmaceutical and biotechnology entities, along with service providers. Their objective is to provide high-quality healthcare to patients all over the globe. At the BioPharma Nexus conferences, players can explore, discover, and generate partnerships for scientific and healthcare collaborations. 

New Jersey has been selected as the venue for hosting the event owing to several reasons. New Jersey is a powerful pharmaceutical corridor and has been pivotal in supporting biotech innovations. Experts and leaders of the biotech & pharma spectrum will attend the event to discuss useful insights on evolving healthcare and share effective strategies to overcome hurdles in clinical operations, patient-centricity, clinical outsourcing, and digital innovation. This event serves as a viable platform for clinical trial service providers to connect with industry leaders and engage in business collaborations.

The attendees at the conference will consist of senior executives and mid-level management from industries in clinical operations, digital health, patient outsourcing, and patient engagement in the US and Europe.

The event agenda consists of presentations by company executives where they showcase their innovative ideas, technology and goals. Aspiring newcomers as well as veterans will speak about their impeccable results in clinical trials. Eminent industry dignitaries will participate in panel discussions and roundtable talks where they delve into finding solutions and strategies for several industry issues. Attendees can engage with peers and brilliant industry minds during the networking breaks and lunch sessions.

To learn more, please visit https://ibn.fm/nRQpt.

From Our Blog

Why 2026 Is a Pivotal Year for Private, Pre-IPO, and Microcap Investing, and What That Means for DealFlow Discovery

January 23, 2026

As we head into January 2026, the capital markets landscape is in a period of subtle but consequential transition, one that has real implications for the direction of private company financings, pre-public valuations, and the small-cap ecosystem that DealFlow Discovery Conference now reflects. For years, microcap investing sat at the intersection of retail enthusiasm and […]

Rotate your device 90° to view site.